We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.72B
AUM Growth
-$344M
Cap. Flow
-$310M
Cap. Flow %
-18%
Top 10 Hldgs %
22.96%
Holding
279
New
14
Increased
72
Reduced
169
Closed
14

Top Buys

Rank Stock Value
1
TTGT icon
TechTarget
TTGT
+$9.17M
2
DOCS icon
Doximity
DOCS
+$7.51M
3
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
+$5.78M
4
CLNE icon
Clean Energy Fuels
CLNE
+$5.35M
5
ZUO
Zuora, Inc.
ZUO
+$4.15M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$26.8M
2
WNS
WNS Holdings
WNS
+$15.7M
3
SIMO icon
Silicon Motion
SIMO
+$14.8M
4
ON icon
ON Semiconductor
ON
+$13.2M
5
WWE
World Wrestling Entertainment
WWE
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 27.05%
2 Healthcare 26.07%
3 Industrials 15.04%
4 Consumer Discretionary 11.17%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UFI icon
276
UNIFI
UFI
$129M
– –
-132,731
Closed -$1.87M
CVET
277
DELISTED
Covetrus, Inc. Common Stock
CVET
– –
-123,334
Closed -$2.56M
IEA
278
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
– –
-287,891
Closed -$2.31M
GBT
279
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-231,435
Closed -$7.39M
8 9 10 11
12

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Rice Hall James & Associates held 279 positions worth $1.72B, down 17% from $2.07B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Rice Hall James & Associates withdrew a net $310M in Q3 2022, closing 14 positions and reducing 169 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $7.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in TechTarget worth $8.44M.

  • Rice Hall James & Associates's largest Q3 2022 buy was TechTarget: 142,597 shares worth $8.44M.
  • Rice Hall James & Associates added most to Upland Software in Q3 2022, an estimated $3.67M increase.
  • Rice Hall James & Associates's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $26.8M.
  • Rice Hall James & Associates fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $7.39M.
  • Rice Hall James & Associates's ten largest holdings make up 23% of its $1.72B portfolio in Q3 2022.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q3 2022.
  • Rice Hall James & Associates's portfolio value fell 17% quarter-over-quarter to $1.72B.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.